Aptus Pharma Ltd (NSE: APPL), ISIN INE15XJ01010 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
APPL last traded at ₹260.00 (-0.02%), with a 52-week range of ₹32.32 to ₹264.00 (as of 30 Jul 2026).
Shareholding as of Dec 2025: promoters 72.89%, FIIs 0.00%, DIIs 0.00%, mutual funds 0.00%.
EquiSense Score (ECS): 74/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.